Willdan SVP Business Development Paul Whitelaw resigns; gets $233K severance, equity acceleration

Willdan Group, Inc.

Paul Whitelaw resigned as SVP Business Development effective February 1, 2023.
Separation agreement provides $233,342 severance (10 months salary) paid in equal installments over 10 months.
All 6,280 unvested shares (3,800 RSA + 2,480 PBRSU at target) fully vest upon separation.
Option exercise period for vested options extended through December 31, 2023.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Paul Whitelaw

Senior Vice President, Business Development

WLDN · Willdan Group, Inc.

Effective: 2023-02-01
Filed: January 24, 2023, 6:59 PM ET

On January 19, 2023, Mr. Paul Whitelaw notified Willdan Group, Inc. (the “Company”) of his resignation from his position as Senior Vice President, Business Development of the Company and from all other positions he holds with the Company and each of its subsidiaries, effective February 1, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Paul Whitelaw resigned as Senior Vice President, Business Development at Willdan Group, Inc..

Action: resigned
Role: Senior Vice President, Business Development

Exact text from the filing

On January 19, 2023, Mr. Paul Whitelaw notified Willdan Group, Inc. (the “Company”) of his resignation from his position as Senior Vice President, Business Development of the Company and from all other positions he holds with the Company and each of its subsidiaries, effective February 1, 2023.

View on SEC.gov

Willdan Group, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-23-000430

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.